BMS Archive

Plant · Scientific monograph

Tribulus terrestris

Puncture Vine

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Male Endocrine Research, Exercise & Physical Performance Research, Androgen Research

Research overview

Historical use

Tribulus terrestris (puncture vine) has been used for centuries in Ayurvedic medicine (as Gokshura) and in Traditional Chinese Medicine for urinary complaints, male reproductive disorders, and as a general tonic for vitality. In Bulgarian folk medicine, the aerial parts were used for libido enhancement and muscle strength, which prompted investigation of the plant's steroidal saponin content beginning in the 1970s. The plant became widely promoted in the sports supplement industry following claims (subsequently disputed in clinical trials) that protodioscin saponins increase serum testosterone via luteinising hormone stimulation.

Modern research context

Clinical evidence for Tribulus terrestris's most marketed applications is largely negative. A 2022 systematic review of 14 RCTs in athletes found no significant effect on testosterone, LH, muscle mass, or athletic performance versus placebo [1]. A 2016 review of androgenic claims concluded that animal data showing LH-mediated testosterone elevation in castrated or hypogonadal models do not translate to eugonadal humans [3]. In contrast, evidence for male sexual dysfunction is more promising: a 2017 RCT (n=180) demonstrated significant improvement in IIEF scores and sexual satisfaction in men with mild-to-moderate erectile dysfunction [2]. A separate RCT showed improvement in sperm parameters in oligospermic men after 90 days of Tribulus extract [4]. Antihypertensive effects via ACE inhibition and diuretic activity documented in animal and in vitro models; no adequate human RCT evidence [5]. Saponin fraction shows reproducible antidiabetic activity (α-glucosidase inhibition) in preclinical studies [5].

Adverse effects

Generally well-tolerated at standard doses in clinical trials. Most common adverse effects: gastrointestinal upset, sleep disturbance, and restlessness. Hepatotoxicity and nephrotoxicity reported in animal studies at supraphysiological doses. Case reports of nephrotoxicity in humans at very high doses. Gynaecomastia reported in one case report (anecdotal). No significant hormonal adverse effects at clinical doses in human trials [1, 2].

Contraindications

Hormone-sensitive conditions (prostate cancer, BPH with elevated PSA) — theoretical androgen pathway activity; avoid. Pregnancy — animal studies show teratogenicity (neural tube defects at high doses in sheep grazing models); contraindicated. Antidiabetic drugs — potential additive hypoglycaemia via α-glucosidase inhibition. Antihypertensives — theoretical additive hypotensive effect [1, 5].

Clinical and phytochemical data

Used part

Aerial parts and fruit (Fructus Tribuli); primarily the fruit in clinical extracts

Primary active compounds

  • Steroidal saponins: protodioscin, protogracillin, dioscin (furostanol and spirostanol glycosides)

  • Flavonoids: quercetin, kaempferol, isorhamnetin

  • Alkaloids: harmine (trace)

  • Tannins and phenolic acids

  • Phytosterols: β-sitosterol, stigmasterol

Mechanism of action

Androgenic (proposed, contested): Protodioscin is claimed to stimulate LH secretion from the pituitary via a hypothalamic mechanism, thereby increasing endogenous testosterone synthesis — this mechanism is demonstrated in castrated animal models but not reproduced in eugonadal human RCTs [3]. PDE-5 inhibition: Saponin fractions inhibit PDE-5 in vitro, increasing cGMP and promoting corporal smooth muscle relaxation — a possible mechanism for observed erectile function improvement [2]. α-Glucosidase inhibition: Steroidal saponins competitively inhibit intestinal α-glucosidase, reducing post-prandial glucose absorption [5]. ACE inhibition: Flavonoid fraction demonstrates angiotensin-converting enzyme inhibition in vitro, potentially contributing to antihypertensive effects [5].

Pharmacokinetics

Absorption

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Furostanol saponins (protodioscin) are partially hydrolysed by gut microbiota and intestinal β-glucosidases prior to absorption. Oral bioavailability of intact saponins is low (<10%) due to high molecular weight and poor membrane permeability.

Distribution

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Aglycone metabolites (diosgenin, gitogenin) are lipophilic and distribute to steroidogenic tissues. Plasma protein binding not characterised.

Metabolism

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Furostanol saponins converted to spirostanol aglycones by gut bacteria; hepatic phase II conjugation (glucuronidation) of aglycone metabolites.

Excretion

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Primarily biliary/faecal excretion for high-molecular-weight saponins; renal excretion of conjugated polar metabolites.

Safety and interactions

Drug interactions

Antidiabetic drugs (insulin, sulfonylureas, metformin) — additive glucose-lowering via α-glucosidase inhibition; monitor blood glucose. Antihypertensives — possible additive hypotension; monitor BP. Anticoagulants — in vitro platelet inhibition reported; clinical significance unknown [5].

Toxicity

Nephrotoxicity documented in animal studies at supraphysiological doses via saponin-induced tubular cell injury. Occasional human nephrotoxicity case reports at high doses. Livestock studies document 'geeldikkop' (hepatogenous photosensitisation) in sheep with high Tribulus grazing — attributed to steroidal saponins; human relevance uncertain at supplemental doses [1].

Special precautions

Pregnancy

Contraindicated. Animal models show neural tube defects and teratogenicity at high doses.

Lactation

No human clinical safety data are available during lactation. The androgenic saponins (protodioscin) in Tribulus terrestris may theoretically affect the hormonal milieu during breastfeeding; potential transfer to breast milk has not been studied. Avoid during lactation due to insufficient safety data and potential androgenic effects on the infant.

Hepatic impairment

Use with caution. Saponin-related hepatotoxicity reported at high doses in animal studies.

Renal impairment

Use with caution. Nephrotoxic potential at high doses; avoid in moderate-severe renal impairment.

Sources and references

  1. [1] - Fernandez-Lazaro D, Mielgo-Ayuso J, Adams DP, González-Bernal JJ, Gutiérrez-Abejón E, Fernandez-Lazaro CI., "Tribulus terrestris L. and Physical Exercise: A Systematic Review and Meta-Analysis.", Nutrients, 2022, PMID: 35408191
  2. [2] - Roaiah MF, El Khayat YI, GamalEl Din SF, Abd El Salam MA., "Pilot Study on the Effect of Botanical Medicine (Tribulus terrestris) on Serum Testosterone Level and Erectile Function in Aging Males with Partial Androgen Deficiency.", J Sex Marital Ther, 2016, PMID: 26681385
  3. [3] - Neychev V, Mitev V., "Pro-sexual and androgen enhancing effects of Tribulus terrestris L.: Fact or Fiction.", J Ethnopharmacol, 2016, PMID: 26727646
  4. [4] - Sellandi TM, Thakar AB, Baghel MS., "Clinical study of Tribulus terrestris Linn. in Oligozoospermia: A double blind study.", Ayu, 2012, PMID: 23723641
  5. [5] - Zhu W, Du Y, Meng H, Dong Y, Li L., "A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris.", Chem Cent J, 2017, PMID: 29086739

Additional source links

Continue browsing